Protagonist Therapeutics shares nearly doubled on Monday: explore why

SoFi Technologies shares on Monday spiked 12% after Morgan Stanley initiated coverage with an overweight rating and $25 price target.

Related Keywords

Leerink Joseph Schwartz ,Dinesh Patel ,Drug Administration On ,Protagonist Therapeutics Inc ,Drug Administration ,Protagonist Therapeutics ,Joseph Schwartz ,